- Previous Close
70.25 - Open
66.19 - Bid 69.06 x --
- Ask 69.20 x --
- Day's Range
69.00 - 70.90 - 52 Week Range
58.31 - 97.20 - Volume
2,719,961 - Avg. Volume
5,607,844 - Market Cap (intraday)
54.301B - Beta (5Y Monthly) -0.43
- PE Ratio (TTM)
29.28 - EPS (TTM)
2.36 - Earnings Date --
- Forward Dividend & Yield 1.00 (1.53%)
- Ex-Dividend Date May 15, 2024
- 1y Target Est
85.65
Shenzhen New Industries Biomedical Engineering Co., Ltd., a bio-medical company, engages in the research, development, production, and sale of clinical laboratory instruments and in vitro diagnostic reagents to hospitals in the People's Republic of China and internationally. It offers immunoassay, biochemistry/electrolyte, molecular diagnostics, point of care testing, lab automation, and integrated system, products. The company was founded in 1995 and is headquartered in Shenzhen, the People's Republic of China.
www.snibe.comRecent News: 300832.SZ
View MorePerformance Overview: 300832.SZ
Trailing total returns as of 12/27/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 300832.SZ
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 300832.SZ
View MoreValuation Measures
Market Cap
54.30B
Enterprise Value
51.72B
Trailing P/E
29.34
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
12.24
Price/Book (mrq)
6.69
Enterprise Value/Revenue
11.66
Enterprise Value/EBITDA
24.49
Financial Highlights
Profitability and Income Statement
Profit Margin
41.72%
Return on Assets (ttm)
14.87%
Return on Equity (ttm)
24.32%
Revenue (ttm)
4.44B
Net Income Avi to Common (ttm)
1.85B
Diluted EPS (ttm)
2.36
Balance Sheet and Cash Flow
Total Cash (mrq)
2.59B
Total Debt/Equity (mrq)
0.06%
Levered Free Cash Flow (ttm)
967.3M